COVID-19 and chronic non-infectious diseases in the patients with fatal outcome according to the Federal Register in Tomsk region

Abstract


The results obtained are based on the data from “Federal Register of Persons with the Novel Coronavirus Infection COVID-19.” The study included the information from 160 deceased patients hospitalized from November 2020 to January 2021 in the repurposed therapeutic departments of the respiratory hospital of Tomsk Regional Clinical Hospital. Almost half of the patients with fatal outcome from COVID-19 were multimorbid (46.3%). The most common combination of CSD and respiratory diseases was found — in 33.1% of cases. A negative correlation was revealed between the length of stay of deceased patients in the hospital and the age of the patients (rs = −0.172; p <0.05).


About the authors

Nadezhda E. Naydenova

Siberian State Medical University

Author for correspondence.
Email: nadiet@mail.ru
ORCID iD: 0000-0002-4085-388X

Russian Federation, Tomsk, Russian Federation

Ekaterina N. Ilyinskikh

Siberian State Medical University,

Email: infsibgmu@list.ru
ORCID iD: 0000-0001-7646-6905

Russian Federation, Tomsk, Russian Federation

Alexander V. Nagaytsev

Siberian State Medical University

Email: nagaicev.av@mail.ru
ORCID iD: 0000-0002-6593-6585

Russian Federation, Tomsk, Russian Federation

Natalya A. Stasyuk

Siberian State Medical University

Email: stasuk.na@ssmu.ru
ORCID iD: 0000-0001-6336-1522

Russian Federation, Tomsk, Russian Federation

Anastasia V. Amonotidi

Tomsk Regional Clinical Hospital

Email: amonotidi.n@gmail.com
ORCID iD: 0009-0008-8651-8287

Russian Federation, Tomsk, Russian Federation

References

  1. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Polyakov D.S., Belenkov Yu.N., Konradi A.O., et al. International register «Dynamics analysis of comorbidities in SARSCoV-2 survivors» (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2021; 26(4):4470 (In Russian). doi: 10.15829/1560-4071-2021-4470
  2. Mehra M.R., Desai S.S., Kuy S.R., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382(26):2582. doi: 10.1056/NEJMoa2007621
  3. Kluge H.H.P., Wickramasinghe K., Rippin H.L., Mendes R., Peters D.H., Kontsevaya A. et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. 2020;395(10238):1678?80. doi: 10.1016/S0140-6736(20)31067—9
  4. Drapkina O.M., Karpov O.E., Loukianov M.M., Martsevich S.Yu., Pulin A.A., Kutishenko N.P. et al. Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP). Preventive medicine. [Profilakticheskaya meditsina]. 2020;23(8):6?13 (in Russian). doi: 10.17116/profmed2020230816
  5. Konradi A.O., Villevalde S.V., Duplyakov D.V., Kozlenok A.V., Melnik O.V., Mikhailov E.N., et al. An open-label multicenter observational study (registry) of patients recovered from coronavirus disease 2019 (COVID-19) with involvement of the cardiovascular system or with baseline severe cardiovascular diseases: rationale, design, and implications for clinical practice. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2021;26(1):4287. (in Russian). doi: 10.15829/1560-4071-2021-4287.
  6. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Y.N., Konradi A.O., Lopatin Y.M., et al. International register «Dynamics analysis of comorbidities in SARS-CoV-2 survivors» (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2020;25(11):4165 (in Russian). doi: 10.15829/1560-4071-2020-4165
  7. Naydenova N.E., Ilyinskikh E.N., Ostrikova O.I., Shilovskaya K.Yu., Komogortseva K.A., Chenusha D.S., et al. COVID19 and chronic non-communicable diseases: analysis of data from the Federal Register in the Tomsk region. Bulletin of Semashko National Research Institute of Public Health. [Byulleten' Natsional'nogo nauchno-issledovatel'skogo instituta obshchestvennogo zdorov'ya imeni N.A.Semashko]. 2023;(3):48—55 (in Russian). doi: 10.25742/NRIPH.2023.03.008
  8. Li B, Yang J., Zhao F., Zhi L., Wang X., Liu L. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531?8. doi: 10.1007/s00392-020-01626-9
  9. Boytsov S.A., Martsevich S.Y., Kutishenko N.P., Drozdova L.Yu., Lukyanov M.M., Zagrebelnyi A.V., et al. Registers in cardiology: their principles, rules and real-word potential.[Cardiovascular Therapy and Prevention. [Kardiovaskulyarnaya terapiya i profilaktika]. 2013;12(1):4?9 (in Russian).
  10. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054?62. doi: 10.1016/S0140-6736(20)30566—3
  11. Molochkov A.V., Karateev D.E., Ogneva E.Yu., Zulkarnaev A.B., Luchikhina E.L., Makarova I.V. et al. Comorbid diseases and predicting the outcome of COVID-19: results of observation of 13,585 patients who were hospitalized in hospitals in the Moscow region. Almanac of Clinical Medicine. [Al'manakh klinicheskoy meditsiny]. 2020;48(S1):S1—10 (in Russian). doi: 10.18786/2072-0505-2020-48-040
  12. Svarovskaya A.V., Shabelsky A.O., Levshin A.V. Charlson comorbidity index in predicting deaths in COVID-19 patients. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal].2022;27(3):4711 (in Russian). doi: 10.15829/1560-4071-2022-4711
  13. Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S. et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262
  14. Mahmoud M., Carmisciano L., Tagliafico L., Muzyka M., Rosa G., Signori A. et al. Patterns of comorbidity and in-hospital mortality in older patients with COVID-19 infection. Front Med (Lausanne). 2021;8:726837. doi: 10.3389/fmed.2021.726837
  15. Gu T., Chu Q., Yu Z., Fa B., Li A., Xu L. et al. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study. BMJ Open. 2020;10(9):e038976. doi: 10.1136/bmjopen-2020-038976
  16. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia — a systematic review, meta-analysis, and meta-regression. Diabetes MetabSyndr. 2020;14(4):395−403. doi: 10.1016/j.dsx.2020.04.018

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2025 ФГБНУ Национальный НИИ Общественного здоровья имени Н.А. Семашко

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: r.bulletin@yandex.ru

Phone: +7 (495) 917-90-41 add. 136



Principal Contact

Kuzmina Uliia Aleksandrovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: r.bulletin@yandex.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies